SB-435495,99.80%
产品编号:Bellancom-19415| CAS NO:304694-39-1| 分子式:C38H40F4N6O2S| 分子量:720.82
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
SB-435495
产品介绍 | SB-435495 是一种有效的、选择性的、可逆的、非共价的、具有口服活性的 Lp-PLA2 抑制剂,IC50 为 0.06 nM。 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
生物活性 | SB-435495 is a potent, selective, reversible, non-covalent and orally active Lp-PLA2 inhibitor with an IC50 of 0.06 nM. | ||||||||||||||||
体外研究 |
SB-435495 抑制 CYP450 3A4 的 IC50 为 10 μM,膜通透性为 0.017 cm/h。 西域 has not independently confirmed the accuracy of these methods. They are for reference only. Western Blot Analysis
Cell Viability Assay
|
||||||||||||||||
体内研究 (In Vivo) |
SB-435495 (10 mg/kg; p.o.; once) 抑制 WHHL 兔血浆 Lp-PLA2 。 西域 has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
体内研究 |
SB-435495 (10 mg/kg; p.o.; once) 抑制 WHHL 兔血浆 Lp-PLA2 。 西域 has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
体内研究 |
SB-435495 (10 mg/kg; p.o.; once) 抑制 WHHL 兔血浆 Lp-PLA2 。 西域 has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
性状 | Solid | ||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 100 mg/mL (138.73 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) | ||||||||||||||||
参考文献 |
|